Hanson & Doremus Investment Management’s Cardinal Health CAH Stock Holding History

Hanson & Doremus Investment Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-200	Closed	-$17K	–	470
2023 Q3	$17K	Buy	+200	New	+$18.1K	﹤0.01%	362
2022 Q4	–	Sell	-58	Closed	-$4K	–	528
2022 Q3	$4K	Hold	58	–	–	﹤0.01%	487
2022 Q2	$3K	Hold	58	–	–	﹤0.01%	505
2022 Q1	$3K	Hold	58	–	–	﹤0.01%	497
2021 Q4	$3K	Hold	58	–	–	﹤0.01%	466
2021 Q3	$3K	Buy	+58	New	+$3.15K	﹤0.01%	456
2021 Q2	–	Sell	-58	Closed	-$4K	–	433
2021 Q1	$4K	Buy	+58	New	+$3.2K	﹤0.01%	448
2019 Q1	–	Sell	-300	Closed	-$13K	–	449
2018 Q4	$13K	Hold	300	–	–	﹤0.01%	368
2018 Q3	$16K	Hold	300	–	–	0.01%	374
2018 Q2	$15K	Sell	300 -370	-55%	-$21K	﹤0.01%	399
2018 Q1	$42K	Buy	670 +370	+123%	+$25.4K	0.01%	316
2017 Q4	$18K	Hold	300	–	–	0.01%	396
2017 Q3	$20K	Hold	300	–	–	0.01%	372
2017 Q2	$23K	Hold	300	–	–	0.01%	351
2017 Q1	$24K	Hold	300	–	–	0.01%	332
2016 Q4	$21.6K	Hold	300	–	–	0.01%	328
2016 Q3	$23K	Buy	+300	New	+$24.2K	0.01%	303

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hanson & Doremus Investment Management's CAH Position: Q4 2023 in Review

Hanson & Doremus Investment Management sold out of Cardinal Health (CAH) in Q4 2023, closing a stake of 200 shares — an estimated $17K sold.

Hanson & Doremus Investment Management first reported a position in CAH in Q3 2016 and held it in 17 quarters. The position peaked at $42K in Q1 2018. 1,038 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

Hanson & Doremus Investment Management reported no remaining Cardinal Health position as of Q4 2023 after selling out during the quarter.
Hanson & Doremus Investment Management sold 200 Cardinal Health shares in Q4 2023, an estimated $17K.
Hanson & Doremus Investment Management first reported a position in Cardinal Health in Q3 2016 and held it in 17 quarters.
Hanson & Doremus Investment Management's Cardinal Health position peaked at $42K in Q1 2018.
1,038 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on Hanson & Doremus Investment Management's 13F filing for Q4 2023, filed 25 Jan 2024.